info@seagull-health.com
SeagullHealth
语言:
search

Relugolix(MYFEMBREE)

Names
MYFEMBREE,Relugolix,瑞卢戈利,复方瑞卢戈利
Indicatons
Relugolix is indicated for patients with heavy menstrual bleeding associated with uterine leiomyoma.
Price:
Manufacturer:
Sumitomo Pharma
Dosage form:
TABLET
Validity period:
24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

MYFEMBREE(Relugolix) Instructions:Uses,Dosage, Side Effects

MYFEMBREE is a medication used to manage conditions such as heavy menstrual bleeding caused by uterine fibroids and moderate to severe pain associated with endometriosis in premenopausal women. It combines three active ingredients: relugolix, a GnRH receptor antagonist; estradiol, an estrogen; and norethindrone acetate, a progestin. 

The medication is available as a fixed-dose combination tablet, and it is crucial to follow the prescribed dosage and administration instructions, including excluding pregnancy before starting treatment. The use of MYFEMBREE can cause side effects, so monitoring and proper medical advice are important throughout treatment.

Generic name
Relugolix(MYFEMBREE)
English name
Relugolix
Alternative Names
MYFEMBREE,Relugolix,瑞卢戈利,复方瑞卢戈利
Drug prices
Indications

Management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.

Management of moderate to severe pain associated with endometriosis in premenopausal women.

Therapeutic Target
Gonadotropin-releasing hormone (GnRH) receptors, estrogen receptors, and progesterone receptors
Active Ingredients
Relugolix 40 mg (GnRH receptor antagonist) Estradiol 1 mg (estrogen) Norethindrone acetate 0.5 mg (progestin)
Dosage Form
TABLET
Specifications
40mg,1mg,1.5mg*28 tablets/bottle
Dosage and Administration

One tablet orally once daily at approximately the same time, with or without food;Start as early as possible after the onset of menses but no later than seven days after menses has started;Recommended total duration of treatment is 24 months.

    Recommended articles
    Related articles
    Dosage and Administration of Relugolix
    Relugolix is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, often formulated as a fixed-dose combination with estrogens (e.g., estradiol) and progestogens (e.g., norethindrone acet...
    What Are the Purchase Channels for Relugolix?
    Relugolix is an innovative gonadotropin-releasing hormone (GnRH) receptor antagonist, which has shown significant efficacy in the treatment of heavy menstrual bleeding associated with uterine fibroids...
    What Are the Indications of Relugolix?
    Relugolix is an oral medication, often used in combination with estradiol and norethindrone acetate to form the fixed-dose combination product relugolix. It is mainly indicated for the treatment of he...
    Side Effects of Relugolix (Orgovyx)
    Relugolix (Orgovyx) is an oral gonadotropin-releasing hormone receptor antagonist indicated for the treatment of advanced prostate cancer. As a novel endocrine therapy, it exhibits significant efficac...
    What are the Precautions for Using Relugolix (Orgovyx)?
    Relugolix (Orgovyx) is a next-generation gonadotropin-releasing hormone receptor antagonist that provides an important treatment option for patients with advanced prostate cancer. As an orally adminis...
    Dosage and Administration, Recommended Dosage of Relugolix (Orgovyx)
    Relugolix (Orgovyx) is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of adult patients with advanced prostate cancer. As a novel endocrine therapy, its ...
    New Drugs
    Infigratinib(Truseltiq)
    Infigratinib(Truseltiq)
    Treatment of previously treated, unresectable locally advanced or metastatic...
    Opicapone(Ongentys)
    Opicapone(Ongentys)
    Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
    Deflazacort(Emflaza)
    Deflazacort(Emflaza)
    Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
    Faricimab-svoa(Vabysmo)
    Faricimab-svoa(Vabysmo)
    Treatment of neovascular age-related macular degeneration, diabetic macular...
    Counselling Service
    Global Drug Search
    Clinical Research Recruitment
    Overseas Medical Treatment
    Remote Consultations
    Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
    Submit
    Business
    • Core products
    • Antitumor drugs
    • General drug
    • Antiviral drugs
    • Biological agents
    Contact Us 
    • mailbox:info@lucius.la
    Welcome to consult
    ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved